Onconetix Inc (ONCO)

$3.56 +0.03 (0.85%)
Market Cap 5.49M
Revenue (ttm) 2.52M
Net Income (ttm) -58.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,328.97%
Debt to Equity Ratio 0.00
Volume 5,800
Avg Vol 140,996
Day's Range N/A - N/A
Shares Out 1.56M
Stochastic %K 61%
Beta 3.39
Analysts Strong Buy
Price Target N/A

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, I...

Industry: Biotechnology
Sector: Healthcare
Phone: 513 620 4101
Address:
201 East Fifth Street, Suite 1900, Cincinnati, United States
Schizoo
Schizoo Oct. 27 at 4:45 PM
$ONCO🤌
0 · Reply
Schizoo
Schizoo Oct. 24 at 6:40 PM
$IXHL $ONCO $ACON have a great weekend all.. see ya next week.. BALLS N PATIENCE... RisK rEtarD 😘🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀
0 · Reply
RCInvestor
RCInvestor Oct. 24 at 3:56 PM
$REVB $ONCO started a position .. fda meeting end of october expect some news
0 · Reply
Schizoo
Schizoo Oct. 24 at 3:28 PM
$ONCO 🤌
0 · Reply
Schizoo
Schizoo Oct. 23 at 6:10 PM
$ONCO
0 · Reply
Schizoo
Schizoo Oct. 23 at 2:18 PM
$YYAI buying after the RS for another longer swing. ❤️ $IXHL 🤌🚀🚀🚀🚀 $ONCO 🤌🚀🚀🚀🚀 Balls n patience 😘
0 · Reply
Schizoo
Schizoo Oct. 23 at 6:42 AM
$ONCO
0 · Reply
Gainlock
Gainlock Oct. 22 at 9:30 PM
$ONCO stuck
0 · Reply
Schizoo
Schizoo Oct. 22 at 3:38 PM
$YYAI im out with some profits... this did what i was waiting for.. still on watch for another swing.. but for now im happy.. Buying more $IXHL ❤️ Bought some more $ONCO for another swing.. ❤️❤️❤️🤌🚀🚀
0 · Reply
aigohm
aigohm Oct. 22 at 12:05 AM
$ONCO it is just like a bank account. Keep saving !!
0 · Reply
Latest News on ONCO
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Sep 26, 2025, 8:30 AM EDT - 4 weeks ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Sep 26, 2025, 8:15 AM EDT - 4 weeks ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Sep 22, 2025, 8:00 AM EDT - 5 weeks ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Jul 16, 2025, 8:17 AM EDT - 3 months ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Jun 16, 2025, 8:22 AM EDT - 4 months ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Jun 11, 2025, 11:30 AM EDT - 4 months ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 4:50 PM EDT - 5 months ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

Onco-Innovations Uplists to Cboe Canada

May 22, 2025, 10:00 AM EDT - 5 months ago

Onco-Innovations Uplists to Cboe Canada

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 24, 2025, 8:45 AM EDT - 7 months ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Mar 19, 2025, 8:00 AM EDT - 7 months ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Dec 12, 2024, 5:00 PM EST - 11 months ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

ENTO OCS VRNA

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 4:45 PM EDT - 1 year ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 1 year ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Crude Oil Rises; Onconetix Shares Spike Higher

Sep 27, 2024, 2:41 PM EDT - 1 year ago

Crude Oil Rises; Onconetix Shares Spike Higher

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Sep 20, 2024, 11:45 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 15, 2024, 6:00 AM EDT - 1 year ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 1 year ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Feb 13, 2024, 6:00 AM EST - 1 year ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 2, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Nov 1, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Blue Water Biotech Issues Letter to Shareholders

Oct 30, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Issues Letter to Shareholders

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 28, 2023, 4:30 PM EDT - 2 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 3, 2023, 1:02 PM EDT - 2 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 2 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 31, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 25, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 17, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 11, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Jul 6, 2023, 5:05 PM EDT - 2 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Jun 28, 2023, 7:55 AM EDT - 2 years ago

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio

Jun 21, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

Jun 14, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights

May 12, 2023, 6:32 PM EDT - 2 years ago

Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY

May 10, 2023, 12:15 PM EDT - 2 years ago

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY

Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer

Apr 26, 2023, 3:44 PM EDT - 2 years ago

Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer

Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®

Apr 25, 2023, 8:00 AM EDT - 2 years ago

Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®

Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company

Apr 24, 2023, 8:00 AM EDT - 2 years ago

Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

Apr 20, 2023, 7:30 AM EDT - 2 years ago

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine

Apr 12, 2023, 8:30 AM EDT - 2 years ago

Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine

Blue Water Vaccines Reports Year 2022 Financial Results and Recent Business Highlights

Mar 9, 2023, 8:30 AM EST - 2 years ago

Blue Water Vaccines Reports Year 2022 Financial Results and Recent Business Highlights

Blue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business Development

Feb 6, 2023, 10:15 AM EST - 2 years ago

Blue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business Development

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates

Feb 1, 2023, 9:15 AM EST - 2 years ago

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates

Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors

Jan 17, 2023, 8:30 AM EST - 3 years ago

Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors

Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco

Jan 9, 2023, 8:30 AM EST - 3 years ago

Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco

Schizoo
Schizoo Oct. 27 at 4:45 PM
$ONCO🤌
0 · Reply
Schizoo
Schizoo Oct. 24 at 6:40 PM
$IXHL $ONCO $ACON have a great weekend all.. see ya next week.. BALLS N PATIENCE... RisK rEtarD 😘🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀
0 · Reply
RCInvestor
RCInvestor Oct. 24 at 3:56 PM
$REVB $ONCO started a position .. fda meeting end of october expect some news
0 · Reply
Schizoo
Schizoo Oct. 24 at 3:28 PM
$ONCO 🤌
0 · Reply
Schizoo
Schizoo Oct. 23 at 6:10 PM
$ONCO
0 · Reply
Schizoo
Schizoo Oct. 23 at 2:18 PM
$YYAI buying after the RS for another longer swing. ❤️ $IXHL 🤌🚀🚀🚀🚀 $ONCO 🤌🚀🚀🚀🚀 Balls n patience 😘
0 · Reply
Schizoo
Schizoo Oct. 23 at 6:42 AM
$ONCO
0 · Reply
Gainlock
Gainlock Oct. 22 at 9:30 PM
$ONCO stuck
0 · Reply
Schizoo
Schizoo Oct. 22 at 3:38 PM
$YYAI im out with some profits... this did what i was waiting for.. still on watch for another swing.. but for now im happy.. Buying more $IXHL ❤️ Bought some more $ONCO for another swing.. ❤️❤️❤️🤌🚀🚀
0 · Reply
aigohm
aigohm Oct. 22 at 12:05 AM
$ONCO it is just like a bank account. Keep saving !!
0 · Reply
trdrersin
trdrersin Oct. 21 at 6:04 PM
$ONCO been holding for a minute now, up and coming runner🤞
0 · Reply
Gainlock
Gainlock Oct. 21 at 4:04 PM
$ONCO 🔑 3.90. 🔑 4.50
0 · Reply
Gainlock
Gainlock Oct. 21 at 3:56 PM
$ONCO come on. break 4 and don’t look back 🤞
0 · Reply
Gainlock
Gainlock Oct. 21 at 1:46 PM
$ONCO no volume?
0 · Reply
TheCycle
TheCycle Oct. 19 at 8:26 PM
Looks like lot of bulls are watching ticker VRME 💎 VRME is readying up to go parabolic next week. They have compliance news+ possible crypto strategy PR, 🔹Management announced a "treasury strategy" to boost interest income in recent earning calls! VRME isn't any other small cap ticker, it's backed up by solid fundamentals and DD. Don't miss this Gem, be early, gap to 2+ Monday! Potentially can see near 5s imo, happend last time.when this got this much attention. $ONCO $VTAK $SPRC $GFAI ..8
0 · Reply
Gainlock
Gainlock Oct. 17 at 5:26 PM
$ONCO fucked up stock
0 · Reply
Gainlock
Gainlock Oct. 17 at 12:09 PM
$ONCO so from 4.20 to back to 3.20s. is it going to 2.50s now ? or will it reverse to go past 5 and more ? ONCO needs some positive news. 🤦🏽‍♂️
0 · Reply
Gainlock
Gainlock Oct. 15 at 4:21 PM
$ONCO no volume fuck
0 · Reply
GoodLife66
GoodLife66 Oct. 15 at 1:13 AM
Make sure you have ticker GIPR on watch for tomorrow. I think GIPR can see a run to $4.X+ with its small float. Lots of eyes are already on it. Going to run fast, make sure you are early bulls. $KLTO $ONCO $GSIW $ADAP ..
1 · Reply
Khaled43
Khaled43 Oct. 14 at 3:58 PM
$ONCO Soon 5 dollars 💵
0 · Reply
Gainlock
Gainlock Oct. 13 at 5:42 PM
$ONCO volume will come above 4. can it go past 4 by tomorrow ?
0 · Reply
StockChiefs
StockChiefs Oct. 12 at 5:40 PM
MTEX has only 600k shares outstanding and started to make its move up Friday! Spiked 100% recently . Looks like once people find MTEX we could see a squeeze up again! Don't miss MTEX . I would rather buy before they run 300% up.. 💎 $HOLO $NCPL $ONCO $BMNR 0!!
0 · Reply